Bioabsorbable Stent/Bioresorbable Scaffold Market Size, Share, Analysis Report

Bioabsorbable Stent/Bioresorbable Scaffold Market By Application Type (Coronary Artery Diseases, Peripheral Artery Diseases); By Material type (Bioresorbable polymer based stents, Bioresorbable metallic stents); By Absorption Type (Slow- absorption stents, Fast- absorption stents); By End Consumers (Hospitals, Cardiac Centers) and by Regional Analysis - Global Forecast by

The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to be around US$ 685 Million by 2028 at a CAGR of 11% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • REVA Medical Inc
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co. Ltd
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    11

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    In drugs, tubing is any device that is inserted into a vessel or alternative internal duct so as to expand the vessel to stop or alleviate a blockage. Historically, such devices are unreal from metal mesh and stay within the body for good or till removed through more surgical intervention. A bioresorbable tubing, (also known as perishable, or naturally-dissolving) serves a similar purpose, however is factory-made from a fabric which will dissolve or be absorbed within the body.

    How Big is The Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

    The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to be around  US$ 685 Million by 2028 at a CAGR of 11% in the given forecast period.

    The major driving factors of Bioabsorbable Stent/Bioresorbable Scaffold Market are as follows:

    • Rapidly Growing Geriatric Population and increased Risk of CAD and PAD within the older
    • robust Product Pipeline

    The restraining factors of Bioabsorbable Stent/Bioresorbable Scaffold Market­ are as follows:

    • Presence of Substitutes

    The Bioabsorbable Stent/Bioresorbable Scaffold Market is segmented on the lines of its material, absorption rate, application end-user and regional. Based on material type, the market is segmented bioresorbable polymer-based stents and bioresorbable metallic stents. Based on absorption type it covers slow-absorption stents and fast-absorption stents. Based on application it covers Coronary Artery Diseases and Peripheral Artery Diseases. Based on end-users it covers hospitals and cardiac centers. Allergy Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:
    1) An overview of the global market for Bioabsorbable Stent/Bioresorbable Scaffold Market.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Bioabsorbable Stent/Bioresorbable Scaffold Market

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Report scope:

    The scope of the report includes a detailed study of Bioabsorbable Stent/Bioresorbable Scaffold Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:

    By Application Type:

    • Peripheral Artery Diseases
    • Coronary Artery Diseases

    By Material type:

    • Bioresorbable metallic stents
    • Bioresorbable polymer based stents    

    By Absorption Type:

    • Fast- absorption stents
    • Slow- absorption stents

    By End Consumers:

    • Hospitals
    • Cardiac Centers

    Reasons to Buy this Report: 

    1) Obtain the most up to date information available on all Bioabsorbable Stent/Bioresorbable Scaffold Market.

    2) Identify growth segments and opportunities in the industry.

    3) Facilitate decision making on the basis of strong historic and forecast of Bioabsorbable Stent/Bioresorbable Scaffold Market.

    4) Assess your competitor’s refining portfolio and its evolution.

    Customization:
    We can offer you custom research reports as per client’s special requirements.

    Below are our new reports:

    Fluoroscopy Equipment Market

    Hysteroscopy Instruments Market

    Intravascular Temperature Management Market

    US Anticoagulation Therapy Market

    Urinary Catheters Market

    1 Introduction    
        1.1    Key Take Aways    
        1.2    Report Description    
        1.3    Markets Covered    
        1.4    Stakeholders    
        1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources 

    2 Market Research Tactics 
        2.1 Research Approach 
        2.2 Primary Research 
        2.3 Secondary Research
        2.4 Vital Industry Insights 
        2.5 Market Size Evaluation 
        
    3 Market Summary 

    4 Quality Market Insights 
        4.1 Bioresorbable Stents Market Overview 
        4.2 By End User 
        4.3 By Application 
        4.4 By Material 
        4.5 Regional Market Snapshot

    5 Market Bioresorbable Stents Market Overview 
        5.1 Introduction 
        5.2 Market Dynamics 
               5.2.1 Drivers
                        5.2.1.1 Rapidly Growing Geriatric Population And Increased Risk Of Cad And Pad In The Elderly
                        5.2.1.2 Strong Product Pipeline
               5.2.2 Restraints
                        5.2.2.1 Presence Of Substitutes
               5.2.3 Opportunities
                        
               5.2.4 Challenges
                       
    6 Regulatory Market Synopsis
        6.1 Introduction 
        6.2 Fda And Ce Approvals 
        6.3 Pma Approvals And Government Certificates

    7 Bioresorbable Stents Market, By Application
        7.1 Introduction 
        7.2 Bioresorbable Metallic Stents 
        7.3 Bioresorbable Polymer-Based Stents

    8 Bioresorbable Stents Market, By Absorption Rate 
        8.1 Introduction 
        8.2 Slow-Absorption Stents 
        8.3 Fast-Absorption Stents

    9 Bioresorbable Stents Market, By Material 
        9.1 Introduction 
        9.2 Coronary Artery Disease 
        9.3 Peripheral Artery Disease

    10 Bioresorbable Stents Market, By End Consumer
         10.1 Introduction 
         10.2 Hospitals 
         10.3 Cardiac Centers

    11 Bioresorbable Stents Market, By Geographic Region 
         11.1 Introduction 
         11.2 North America
         11.3 Europe
         11.4 Asia Pacific
         11.5 Rest Of The World

    12 Competitive Landscape 
         12.1 Introduction 
         12.2 Market Ranking Analysis 
         12.3 Competitive Leadership Analysis 
         12.4 Competitive Benchmarking 
                 12.4.1 Strength Of The Product Portfolio
                 12.4.2 Business Strategy Excellence

    13 Company Profiles 
    (Company Overview, Product Portfolio, Financial Overview, Key Devolopements)*
         13.1 Kyoto Medical Planning  Co., Ltd. 
         13.2 Reva Medical, Inc. 
         13.3 Elixir Medical Corporation 
         13.4 480 Biomedical 
         13.5 Biotronik 
         13.6 Amaranth Medical, Inc. 
         13.7 Arterial Remodeling Technologies 
         13.8 Meril Life Sciences Pvt. Ltd. 
         13.9 Arterius Limited 
         13.10 Orbusneich
         13.11 Boston Scientific Corporation 
         13.12 Lepu Medical Technology Co., Ltd. 
         13.13 S3v Vascular Technologies Private Limited 
         13.14 Qualimed (Part Of Q3 Medical Group) 
         13.15 Abbott 

    The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:

    By Application Type:

    • Peripheral Artery Diseases
    • Coronary Artery Diseases

    By Material type:

    • Bioresorbable metallic stents
    • Bioresorbable polymer based stents    

    By Absorption Type:

    • Fast- absorption stents
    • Slow- absorption stents

    By End Consumers:

    • Hospitals
    • Cardiac Centers

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 11% during the study period (2023-2028)
    The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to be around US$ 685 Million by 2028.
    The segment included in Bioresorbable Scaffold Market is Material, Applications, Absorption, End Consumers and region.
    Some key players operating in the Bioresorbable Scaffold Market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan)
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports